<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wedel J</submitter><funding>NIH NIAID</funding><funding>Isabella Julian Forrest Foundation</funding><funding>Casey Lee Ball Foundation</funding><pagination>e172218</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12208552</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>135(13)</volume><pubmed_abstract>Coinhibitory receptors function as central modulators of the immune response to resolve T effector activation and/or to sustain immune homeostasis. Here, using humanized SCID mice, we found that neuropilin-2 (NRP2) is inducible on late effector and exhausted subsets of human CD4+ T cells and that it is coexpressed with established coinhibitory molecules including PD-1, CTLA4, TIGIT, LAG3, and TIM3. In murine models, we also found that NRP2 is expressed on effector memory CD4+ T cells with an exhausted phenotype and that it functions as a key coinhibitory molecule. Knockout (KO) of NRP2 resulted in hyperactive CD4+ T cell responses and enhanced inflammation in delayed-type hypersensitivity and transplantation models. After cardiac transplantation, allograft rejection and graft failure were </pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection.</pubmed_title><pmcid>PMC12208552</pmcid><funding_grant_id>N/A</funding_grant_id><funding_grant_id>R01AI148539</funding_grant_id><pubmed_authors>Nakayama H</pubmed_authors><pubmed_authors>Briscoe DM</pubmed_authors><pubmed_authors>Bose S</pubmed_authors><pubmed_authors>Liu K</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>MacLeod K</pubmed_authors><pubmed_authors>Wedel J</pubmed_authors><pubmed_authors>Lee JW</pubmed_authors><pubmed_authors>Bielenberg DR</pubmed_authors><pubmed_authors>Kochupurakkal N</pubmed_authors><pubmed_authors>Maslyar M</pubmed_authors><pubmed_authors>Kong SW</pubmed_authors><pubmed_authors>Alsairafi B</pubmed_authors><pubmed_authors>Komatsu M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection.</name><description>Coinhibitory receptors function as central modulators of the immune response to resolve T effector activation and/or to sustain immune homeostasis. Here, using humanized SCID mice, we found that neuropilin-2 (NRP2) is inducible on late effector and exhausted subsets of human CD4+ T cells and that it is coexpressed with established coinhibitory molecules including PD-1, CTLA4, TIGIT, LAG3, and TIM3. In murine models, we also found that NRP2 is expressed on effector memory CD4+ T cells with an exhausted phenotype and that it functions as a key coinhibitory molecule. Knockout (KO) of NRP2 resulted in hyperactive CD4+ T cell responses and enhanced inflammation in delayed-type hypersensitivity and transplantation models. After cardiac transplantation, allograft rejection and graft failure were </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-06-01T15:31:49.139Z</modification><creation>2026-04-08T13:44:39.872Z</creation></dates><accession>S-EPMC12208552</accession><cross_references><pubmed>40590224</pubmed><doi>10.1172/JCI172218</doi></cross_references></HashMap>